Non-drug Healthcare Resource Use in Adult Patients with Attention-deficit/hyperactivity Disorder - 09/06/15
Résumé |
Introduction |
Non-drug-related healthcare resource use represents an under-investigated contribution to the total healthcare cost of adult patients with attention-deficit/hyperactivity disorder (ADHD).
Objectives |
To assess non-drug healthcare resource use in adult patients with ADHD undergoing pharmacotherapy.
Methods |
Practising psychiatrists in Scotland, Sweden and Denmark were invited from a healthcare professional database to complete an online survey between January and August 2014. Resource use estimations were based on typical adult patients (≥18 years) diagnosed with ADHD and showing either adequate or inadequate responses to ADHD medication.
Results |
Participating psychiatrists in Scotland (n=20), Sweden (n=20) and Denmark (n=15) saw a mean (standard deviation [SD]) of 10.3 (8.2), 17.8 (12.7) and 16.9 (16.5) adult patients with ADHD per month, respectively. Methylphenidate was the most commonly utilised first-line medication (74% of psychiatrists). Tables 1 and 2 show mean prescribed daily drug doses and resource use estimates.
Conclusions |
Findings suggest that patients with an inadequate response to pharmacotherapy consume more non-drug healthcare resources than those with an adequate response. Whilst limited in sample size, this study provides initial data on non-drug healthcare resource use in adult ADHD.
Table 1. Daily drug dose (mg) by country. n/a, not asked.
Table 1. Daily drug dose (mg) by country. n/a, not asked. Le texte complet de cet article est disponible en PDF.
Vol 30 - N° S1
P. 1608 - mars 2015 Retour au numéro
Article précédent
- Cost–utility Analysis of Lisdexamfetamine Dimesylate in the Treatment of Adults with Attention-deficit/hyperactivity Disorder in the United Kingdom
- E.A. Zimovetz, M. Bischof, A. Joseph, J.A. Mauskopf
- Prescription Patterns Among Spanish Inpatients with Schizophrenia
- R. Oberguggenberger, N. Ruiz, M. Ortega, Y. Rendal, C. Roset, E. Lago, J. Salva, P. Herbera
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?